Related Experiment Videos
[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals]
1China Oxford Centre for International Health Research Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Insights
Statin medication is underused in high-risk patients with atherosclerotic cardiovascular diseases in China. This study highlights a significant gap in secondary prevention, indicating a need for improved healthcare strategies.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Pharmacotherapy
Context:
- Atherosclerotic cardiovascular diseases (CVD) represent a major global health burden.
- Secondary prevention strategies are crucial for managing high-risk patients.
- Understanding current treatment patterns is essential for improving patient outcomes.
Purpose:
- To assess the prevalence and patterns of statin use in high-risk patients with atherosclerotic CVD in Chinese hospitals.
- To identify disparities between guideline recommendations and actual clinical practice regarding statin prescription.
Summary:
- A study of 11,783 patients with atherosclerotic CVD across 39 top Chinese hospitals revealed significant underutilization of statins.
- Statin therapy was not prescribed in 59.6% of eligible patients.
- Prescription rates varied, with only 19.6% of ischemic stroke patients and 59.2% of coronary heart disease patients receiving statins.
Impact:
- Findings indicate a substantial gap between recommended and actual statin use for secondary prevention of atherosclerotic CVD in China.
- Urgent interventions are needed from healthcare professionals and policymakers to address this underuse.
- Improving statin adherence can significantly reduce cardiovascular events and mortality in high-risk populations.
Objective:
To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.
Methods:
Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities.
Results:
Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%.
Conclusion:
Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis IV: Nursing Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...